The status of newborn infants born to women with hypertensive disorders
Abstract
The status of 239 newborn infants born to mothers with hypertensive syndrome (a study group) and that of 51 neonates from healthy mothers (a control group) were analyzed. Neonatal mortality and morbidity rates were studied in relation to gestational age and the type and severity of hypertensive disorders. Hypertensive disorders in pregnancy were found to lead to still birth in 2,1% of cases, late miscarriage in 12,1%, prematurity in 47,7%, and intrauterine growth retardation in 27,6%. The incidence of diseases in the infants born to hypertensive mothers was 6,6 times higher than that in those from healthy mothers. The most common nosological entities among the newborn infants were intracranial hemorrhage (29,3%), respiratory distress syndrome (20,1%), hypoxic-ischemic brain damage (22,6%), polycythemia (8,4%), and hyperbihrubinemia (8,8%). Reproductive losses in hypertensive disorders accounted for 17,2% and occurred in 70,7% of cases in the early postnatal period. Severe pathology and prematurity are responsible for high neonatal morbidity and mortality rates.
About the Author
N. A. Shakhbazova
Research Institute of Obstetrics and Gynecology, Baku, Azerbaijan
Azerbaijan
Azerbaijan
References
1. Bell M.J., Carpenter J., Keating R. et al. Development of a Pediatric Neurocritical Care Service — A Single-Center's Experience. Neurocrit Care 2009; 10: 4—10.
2. Richter C. Eclampsia complicated by abdominal compartment syndrome. Am J Perinatal 2009; 26: 10: 751—753.
3. Ycesoy G., Ozkan S., Bodur H. et al. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center. Arch Gynecol Obstet 2005; 273: 1: 43—49.
4. Hutcheon J.A., Lisonkova S., Joseph K.S. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011; 25: 4: 391—403.
5. Fabry I.G., Richart Т., ChengzX. et al. Diagnosis and treatment of hypertensive disorders during pregnancy. Acta Clin Belg 2010; 65: 4: 229-236.
6. Jim В., Sharma S., Kebede T. et al. Hypertension in pregnancy: a comprehensive update. Cardiol Rev 2010; 18: 4: 178—189.
7. Шалина Р.И., Шарапова О.Ж., Выхристюк Ю.В. Тяжелый гестоз. Ближайшие результаты развития детей. Вопр гинекол, акуш и перинатол 2007; 4: 43—48 (Shalina R.I., Sharapova O.Sh., Vykhristyuk Y. Severe preeclampsia. Immediate results of the development of children. Vopr ginekol, akush i perinatal 2007; 4: 43—48.)
8. Макацария А.Д., БицадзеВ. О., Баймурадова СМ. и др. Профилактика повторных осложнений беременности в условиях тромбофилии. Руководство для врачей. М: Триада-X 2008; 152. (Makatsaria A.D., Bicadze V.O., Baymuradova СМ. et al. Prevention of recurrent pregnancy complications in thrombophilia. A guide for doctors. M Triada-X 2008; 152.)
9. Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. NICE Clinical Guidelines, No. 107. National Collaborating Centre for Womens and Childrens Health (UK). London: RCOG Press 2010; 78.
10. Karthikeyan V.J., Lip G. Y. Endothelial damage/ dysfunction and hypertension in pregnancy. Front Biosci 2011; 3:1100—1108.
11. Lazdam M., Davis E.F., Lewandowski A.J. et al. Prevention of Vascular Dysfunction after Preeclampsia: A Potential Long-Term Outcome Measure and an Emerging Goal for Treatment. J Pregnancy 2012; 2012: 704146. doi: 10.1155/2012/704146.
12. Thale V., Schlitt A. Hypertensive diseases in pregnancy. Internist (Berl.) 2008; 49: 7: 811—816.
13. Uzan J., Carbonnel M., Piconnel O. et al. Pre-eclampsia: pathophysiology diagnosis and management. Vascular Health and Risk Management 2011; 7: 467—474.
14. Levels and trends in child mortality. World Health Organization. Geneva 2012; 32.
15. Потапов С.Н. Морфологические особенности клеток сперматогенного эпителия плодов и новорожденных от матерей с преэклампсией. Експерим. i клш. мед 2009; 3: 18—21. (Potapov S. Morphological features of spermatogenic epithelium of fetuses and newborns of mothers with preeclampsia. Eksperim. iklin. med2009; 3: 18—21.)
16. Levine R.J., Vatten L.J., Horowitz G.L. et al. Preeclampsia, soluble fmslike tyrosine kinase 1, and the risk of reduced thyroid function: nested case control andpopulationbased study. Br Med J 2009; 339:7734:1355-1359.
Review
For citations:
Shakhbazova N.A. The status of newborn infants born to women with hypertensive disorders. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2014;59(5):36-38. (In Russ.)
Views:
721
Email this article 